Epitomee Medical

About:

Epitomee Medical is a drug-free, self-administered shapeshifting capsule, for inducing weight loss and preventing diabetes.

Website: https://www.epitomeemedical.com/

Top Investors: XT Venture Capital, GCB Services, Shimon Eckhouse

Description:

Epitomee develops paradigm-shifting ingestible devices that deploy targeted therapies along the GI tract. The company develops and commercializes ingestible therapeutic devices with the goal of addressing some of today's most common chronic diseases in a self-managed, safer, kinder to the system, and more manageable manner. Their technology is based on self-expanding hydro-gel scaffolds folded into a standard pharmaceutical capsule, produced from biocompatible excipients, food additives, and food contact materials.

Total Funding Amount:

$8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Caesarea, Hefa, Israel

Founded Date:

2005-01-01

Contact Email:

info(AT)epitomeemedical.com

Founders:

Shimon Eckhouse

Number of Employees:

11-50

Last Funding Date:

2019-04-09

IPO Status:

Public

Industries:

© 2025 bioDAO.ai